We model AML pathogenesis based on known behavior of a genetic Cbfb-MYH11 (CM) knock-in mouse model that recapitulates somatic acquisition of a chromosomal rearrangement, inv(16)(p13q22) [28, 29], commonly found in approximately 12 percent of AML cases. The gene discussed is MYH11; the disease is acute myeloid leukemia.